Search Results - "BESSES, CARLES"

Refine Results
  1. 1
  2. 2
  3. 3

    Hematological disorders: a commonly unrecognized cause of acute stroke by Arboix, Adrià, Jiménez, Carme, Massons, Joan, Parra, Olga, Besses, Carles

    Published in Expert review of hematology (01-09-2016)
    “…Hematological disorders account for about 1.3% of all causes of acute stroke. This systematized review presents updated information on the implications of this…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Pemphigus‐like hypereosinophilic syndrome with FIP1L1–PDGFRA fusion gene: A challenging and uncommon clinical presentation by Curto‐Barredo, Laia, Segura, Sonia, Ishii, Norito, Hashimoto, Takashi, Mascaró, José M., Espinet, Blanca, Besses, Carles, Pujol, Ramon M.

    Published in Journal of dermatology (01-06-2019)
    “…Hypereosinophilic syndrome (HES) is often associated with cutaneous manifestations, mostly pruritic lesions, urticaria and angioedema. Mucosal lesions are…”
    Get full text
    Journal Article
  8. 8

    Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome by García, Mar, Bellosillo, Beatriz, Sánchez-González, Blanca, García-Payarols, Francesc, Seoane, Agustin, Ferrer, Ana Maria, Gimeno, Eva, Barranco, Luis Eugenio, Torner, Ariadna, Solé, Francesc, Besses, Carles, Serrano, Sergi, Salar, Antonio

    Published in PloS one (19-12-2012)
    “…FOXP3+ regulatory T cells (Treg) play an essential role in modulating host responses to tumors and infections. The role of these cells in the pathogenesis of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib by March-Rodriguez, Álvaro, Bellosillo, Beatriz, Álvarez-Larrán, Alberto, Besses, Carles, Pujol, Ramon M, Toll, Agustí

    Published in Annals of dermatology (01-04-2019)
    “…Ruxolitinib is a Janus kinase (JAK)1 and JAK2 inhibitor approved for the treatment of myelofibrosis and for polycythemia patients who are resistant or…”
    Get full text
    Journal Article
  12. 12

    JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis by Martinez-Aviles, Luz, Besses, Carles, Alvarez-Larran, Alberto, Cervantes, Francisco, Hernandez-Boluda, Juan Carlos, Bellosillo, Beatriz

    Published in Haematologica (Roma) (01-12-2007)
    “…* Departments of Pathology and ° Clinical Hematology Hospital del Mar, IMAS, Barcelona; # Department of Hematology, Hospital Clínic, University of Barcelona; @…”
    Get full text
    Journal Article
  13. 13

    FISH is better than BIOMED-2 PCR to detect IgH/ BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections by Espinet, Blanca, Bellosillo, Beatriz, Melero, Carme, Vela, Mª Carmen, Pedro, Carmen, Salido, Marta, Pijuan, Lara, Florensa, Lourdes, Besses, Carles, Serrano, Sergi, Solé, Francesc

    Published in Leukemia research (01-05-2008)
    “…The most common genetic aberration in follicular lymphoma (FL) is the t(14;18)(q32;q21) translocation that juxtaposes the antiapoptotic BCL2 gene with the…”
    Get full text
    Journal Article
  14. 14

    Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells by Fernández-Rodríguez, Concepción, Salar, Antonio, Navarro, Alfons, Gimeno, Eva, Pairet, Silvia, Camacho, Laura, Ferraro, Mariana, Serrano, Sergi, Besses, Carles, Bellosillo, Beatriz, Sanchez-Gonzalez, Blanca

    Published in Leukemia & lymphoma (03-03-2016)
    “…Current standard-of-care therapy for diffuse large B-cell lymphoma (DLBCL) results in up to 40% of patients who either relapse or develop refractory disease…”
    Get full text
    Journal Article
  15. 15

    Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms by Angona, Anna, Alvarez-Larrán, Alberto, Bellosillo, Beatriz, Longarón, Raquel, Camacho, Laura, Fernández-Rodríguez, M. Concepción, Pairet, Silvia, Besses, Carles

    Published in Leukemia research (01-09-2016)
    “…•CALR-mutated ET patients harbored a higher mutant load at progenitor level than JAK2-positive ET.•Hematopoietic stem cells of CALR-mutated ET showed a similar…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up by Senín, Alicia, Fernández-Rodríguez, Concepción, Bellosillo, Beatriz, Camacho, Laura, Longarón, Raquel, Angona, Anna, Besses, Carles, Álvarez-Larrán, Alberto

    Published in Annals of hematology (01-03-2018)
    “…JAK2 V617F monitoring and NGS of non-driver genes was performed in 100 patients with polycythemia vera (PV) or essential thrombocythemia (ET) with long…”
    Get full text
    Journal Article
  19. 19
  20. 20